News Buzz: Atara Biotherapeutics, Inc. (NASDAQ:ATRA), Delta Air Lines, Inc. (NYSE:DAL), CR Bard Inc. (NYSE:BCR), Thermon Group Holdings, Inc. (NYSE:THR), Balchem (NASDAQ:BCPC)

On 6 August, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) reported financial results for the second quarter ended June 30, 2015. The company reported a net loss of $14.9 million, or $0.62 per share, for the second quarter of 2015, compared to a net loss of $4.5 million, or $3.37 per share, for the second quarter of 2014. The increase in net loss in the second quarter of 2015 was primarily due to higher costs related to expanded clinical research and development activities.Atara Biotherapeutics, Inc. (NASDAQ:ATRA) belongs to Healthcare sector. Its weekly performance is -7.77%. On last trading day company shares ended up $51.78. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) distance from 50-day simple moving average (SMA50) is -1.05%.

On 29 July, Delta Air Lines, Inc. (NYSE:DAL) said that, it is paying $450 million for a stake in China Eastern Airlines, a move the carrier hopes will help it gain access to China’s burgeoning travel market. Delta Air Lines, Inc. (NYSE:DAL) shares increased 0.67% in last trading session and ended the day at $46.35. DAL Gross Margin is 46.20% and its return on assets is 3.50%. Delta Air Lines, Inc. (NYSE:DAL) quarterly performance is 0.68%.

On 5 August, CR Bard Inc. (NYSE:BCR) agreed to pay more than $200 million to resolve at least 3,000 cases by women injured by the company’s vaginal-mesh inserts. On 07 August, CR Bard Inc. (NYSE:BCR) shares moved down -0.20% and was closed at $198.57. BCR EPS growth in last 5 year was -4.00%. CR Bard Inc. (NYSE:BCR) year to date (YTD) performance is 19.64%.

On 5 August, Thermon Group Holdings, Inc. (NYSE:THR) announced consolidated financial results for the first quarter of the fiscal year ending March 31, 2016 (“Q1 2016”). Q1 2016 includes $4.6 million of revenue generated by our two recently acquired businesses. Excluding a $5.9 million negative impact from foreign currency fluctuations, Q1 2016 revenue would have been $71.1 million, or 5% growth over Q1 2015. Thermon Group Holdings, Inc. (NYSE:THR) ended the last trading day at $23.01. Company weekly volatility is calculated as 3.29% and price to cash ratio as 7.88. Thermon Group Holdings, Inc. (NYSE:THR) showed a weekly performance of -4.64%.

On 6 August, Balchem Corp. (NASDAQ:BCPC) has reported a 53.27 percent jump in profit for the quarter ended Jun. 30, 2015. The company has earned $14.92 million, or $0.47 a share in the quarter, compared with $9.73 million, or $0.31 a share for the same period last year. Balchem Corp. (NASDAQ:BCPC) shares increased 0.26% in last trading session and ended the day at $61.72. BCPC Gross Margin is 27.30% and its return on assets is 6.80%. Balchem Corp. (NASDAQ:BCPC) quarterly performance is 7.94%.

Leave a Reply

Your email address will not be published. Required fields are marked *